Assoc. Prof. NECİBE BAŞARAN MUTLU AĞARDAN

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Preparation and evaluation the effects of retinoic acid loaded proliposomal nanofibers on microbial biofilm inhibition

TORT S., ÖZTÜRK Z. C., KAYNAK ONURDAĞ F., Mutlu-Agardan N. B.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , 2024 (SCI-Expanded)

Evaluation of the effect of process parameters on the protein content of silk fibroin

Yıldız A., MUTLU AĞARDAN N. B., ACARTÜRK F.

Polymer Bulletin , vol.80, no.12, pp.13181-13198, 2023 (SCI-Expanded)

Cholesterol included self-assembled electrospun proliposomes as a feasible approach for drug delivery

Mutlu-Ağardan N. B., TORT S.

Journal of Drug Delivery Science and Technology , vol.86, 2023 (SCI-Expanded)

A New Insight to Silver Sulfadiazine Antibacterial Dressings: Nanoparticle-Loaded Nanofibers for Controlled Drug Delivery

Mutlu-Ağardan N. B., Tort S., Aydoğduoğlu Ş., Kıymacı M. E.

AAPS PHARMSCITECH , vol.24, no.1, 2023 (SCI-Expanded) Sustainable Development

Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines

Pinar S. G., PEZİK E., Agardan B. M., Celebi N.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.27, no.1, pp.52-62, 2022 (SCI-Expanded)

Development of effective AmB/AmB–αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment

Mutlu-Agardan N. B., Yilmaz S., KAYNAK ONURDAĞ F., Celebi N.

Journal of Liposome Research , vol.31, no.2, pp.177-188, 2021 (SCI-Expanded)

<i>In vitro</i> and <i>in vivo</i> evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin delivery.

Mutlu-Agardan N. B., Han S.

Pharmaceutical development and technology , vol.26, pp.157-166, 2021 (SCI-Expanded)

In vitroandin vivoevaluation of microneedles coated with electrosprayed micro/nanoparticles for medical skin treatments

TORT S., MUTLU AĞARDAN N. B., Han D., Steckl A. J.

JOURNAL OF MICROENCAPSULATION , vol.37, no.7, pp.517-527, 2020 (SCI-Expanded) Sustainable Development

Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer

Agardan N. B., Degim Z., Yilmaz S., Altintas L., Topal T.

Journal of Drug Delivery Science and Technology , vol.57, 2020 (SCI-Expanded) Sustainable Development

Cytotoxicity of Novel Redox Sensitive PEG2000-S-S-PTX Micelles against Drug-Resistant Ovarian and Breast Cancer Cells

Mutlu-Agardan N. B., Sarisozen C., Torchilin V. P.

Pharmaceutical Research , vol.37, no.3, 2020 (SCI-Expanded) Sustainable Development

Redox-triggered intracellular siRNA delivery

MUTLU AĞARDAN N. B., Sarisozen C., Torchilin V. P.

CHEMICAL COMMUNICATIONS , vol.54, no.49, pp.6368-6371, 2018 (SCI-Expanded) Sustainable Development

The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy

MUTLU AĞARDAN N. B., Degim Z., Yilmaz S., Altintas L., Topal T.

AAPS PHARMSCITECH , vol.17, no.4, pp.968-977, 2016 (SCI-Expanded)

Antitumoral and MMP-2 inhibition activity of raloxifene or tamoxifen loaded nanoparticles containing dimethyl-beta-cyclodextrin

Agardan N. B., Degim Z., Yilmaz S.

JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.80, pp.31-36, 2014 (SCI-Expanded) Sustainable Development

New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations

MUTLU AĞARDAN N. B., Degim Z., Yilmaz S., EŞSİZ D., NACAR A.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.7, pp.775-789, 2011 (SCI-Expanded)

Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2)

Degim Z., Mutlu N. B., Yilmaz S., Essiz D., Nacar A.

Pharmazie , vol.65, no.1, pp.32-40, 2010 (SCI-Expanded) Sustainable Development

DEVELOPMENT OF LIPOSOME FORMULATION OF RIVASTIGMINE AND INVESTIGATION OF TRANSPORT PROPERTIES THROUGH MDCK AND CACO-2 CELL LINES

Degim Z., MUTLU AĞARDAN N. B., Yilmaz S., EŞSİZ D.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.38, no.1, pp.88-89, 2009 (SCI-Expanded)

Articles Published in Other Journals

AN OVERWIEW OF TARGETED DRUG DELIVERY SYSTEMS FOR RHEUMATOID ARTHRITIS TREATMENT ROMATOID ARTRIT TEDAVISINDE HEDEFLENDIRILMIŞ ILAÇ TAŞIYICI SISTEMLERE GENEL BAKIS

Durmaz N., Aǧardan N. B.

Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.48, no.1, pp.1-15, 2023 (Scopus)

Recent Advances in Oral Insulin Therapy by Nanoparticulate Drug Delivery Systems: Systematic Review

Mutlu Ağardan N. B.

Literatür Eczacılık Bilimleri Dergisi , vol.11, no.1, pp.104-118, 2022 (Peer-Reviewed Journal)

AN OVERVIEW OF SUBUNIT-BASED VACCINES FOR PULMONARY ADMINISTRATION

Ongun M., Mutlu Ağardan N. B., Acartürk F.

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , vol.45, no.1, pp.109-130, 2021 (Scopus) Sustainable Development

Studies on the formulation optimization and controlled ionic gelation of chitosan nanoparticles using TPP-HP-beta-CD inclusion complex

Agardan M.

ISTANBUL JOURNAL OF PHARMACY , vol.50, no.1, pp.54-59, 2020 (ESCI)

Development of Liposome Formulations ofTamoxifen and Assessment of Caco-2 CellTransportation Properties

MUTLU AĞARDAN N. B., DEĞİM Z., Yılmaz Ş.

FABAD J. Pharm. Sci , vol.43, no.1, pp.1-6, 2018 (Scopus)

Bioavailability file: Rivastigmine tartrate

Mutlu N. B., Deǧim Z.

Fabad Journal of Pharmaceutical Sciences , vol.30, no.3, pp.150-157, 2005 (Scopus)

Refereed Congress / Symposium Publications in Proceedings

Development of Mesalazine Loaded Hydrogel Formulations by 3D Printing Technology

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

20th International Pharmaceutical Technology Symposium, Ankara, Turkey, 21 - 23 February 2022

Optimization and validation of silk fibroin production process

Yıldız A., MUTLU AĞARDAN N. B., ACARTÜRK F.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 08 September 2021, pp.144

The effects of a new cyclosporine A nanosuspension on nephrotoxicity after oral administration: HK-2 cell culture and in vivo histopathological evaluation

GÜLBAĞ PINAR S., MUTLU AĞARDAN N. B., IŞIK GÖNÜL İ., ÇELEBİ F. N.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 08 September 2021

Studies on formulation optimisation of hyaluronic acid coated chitosan nanoparticles loaded with hydrocortisone acetate

Durmaz N., MUTLU AĞARDAN N. B.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 08 September 2021, pp.149

Preparation of chitosan tripolyphosphate and chitosan sulfobutyl-ether-β-cyclodextrin nanoparticles for oral insulin delivery

Turan T., MUTLU AĞARDAN N. B.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 08 September 2021, pp.109

Optimization and Validation of Silk Fibroin Production Process

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

3rd International Gazi Pharma Symposium Series, Ankara, Turkey, 8 - 10 September 2021

Romatoid Artrit Tedavisinde Kullanılmak Üzere Hedeflendirilmiş Nanopartiküllerin Deney Tasarımı ile Geliştirilmesi Üzerine Çalışmalar

Durmaz N., MUTLU AĞARDAN N. B.

7th International Hippocrates Congress on Medical and Health Sciences, Ankara, Turkey, 03 September 2021

Studies on modifications of established silk fibroin production methods to enhance protein content

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Viyana, Austria, 11 - 15 May 2021

Studies on modifications of established silk fibroin production methods to enhance protein content

Yıldız A., MUTLU AĞARDAN N. B., ACARTÜRK F.

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Turkey, 11 May 2021

Development of Amphotericin B loaded chitosan sulfobutylether-β-cyclodextrin nanoparticles with sodium deoxycholate

MUTLU AĞARDAN N. B.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019

Evaluation of Dissolution Properties of Cyclosporine a Nanosuspensions Prepared with Two Different Top Down Technologies

GÜLBAĞ S., MUTLU AĞARDAN N. B., ÇELEBİ F. N.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019

The Effect of Process Parameters of the Cyclosporine A Nanosuspension Produced by Wet Milling Stabilized with Hydroxypropyl methylcellulose

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., ÇELEBİ F. N.

Controlled Release Society (CRS) Annual Meeting Exposition, Valencia, Spain, 21 - 24 July 2019

AmB / AmB-αCD çifte yüklü lipozomların antifungal etkinlik ve sitotoksisite çalışmaları

MUTLU AĞARDAN N. B., KAYNAK ONURDAĞ F., yılmaz ş., çelebi n.

2. Ulusal Marmara Eczacılık Kongresi (UMEK-2), İstanbul, Turkey, 14 - 16 November 2018

Preformulation studies of cyclosporine A nanosuspension stabilized by hydroxypropyl methylcellulose and soluplus

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., Çelebi N.

12th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 26 - 29 June 2018

Top down production of cyclosporine A nanosuspensions: Formulation design and characterization for oral delivery

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., ÇELEBİ N.

EUFEPS Annual Meeting 2018, Atina, Greece, 24 - 26 May 2018

Studies on formulation development of amphotericin B-double loaded liposomes using design of experiment (DoE)

MUTLU AĞARDAN N. B., Çelebi N.

EUFEPS Annual Meeting 2018, Atina, Greece, 24 - 26 May 2018

Development of Amphotericin B-double loaded liposomes using design of experiment (DoE)

MUTLU AĞARDAN N. B., Çelebi N.

16th International Conference and Exhibition on Pharmaceutics Novel Drug Delivery Systems, Berlin, Germany, 19 - 21 March 2018, vol.47, pp.88

Preparation and characterization of cyclosporine A nanosuspensions for oral administration II: The effect of Poloxamer types on physical stability of formulations

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., Çelebi F. N.

11th WORLD MEETING on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Nicaragua, 19 - 21 March 2018

Redox potential sensitive smart nanopreparations for drug and siRNA delivery in cancer

MUTLU AĞARDAN N. B.

16th International Conference and Exhibition on Pharmaceutics Novel Drug Delivery Systems, Berlin, Germany, 19 - 21 March 2018, vol.7, pp.46 Sustainable Development

STUDIES ON ABSORPTION ENHANCEMENT OF TAMOXIFEN BY LIPOSOME FORMULATIONS

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., ALTINTAŞ L.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017

ANTITUMORAL AND MMP-2 ENZYME INHIBITION ACTIVITIES OF RALOXIFENE NANOCOCHLEATES ON MCF-7 AND MDA MB-231 CELL LINES

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş.

2nd International Gazi Pharma Symposium Series, 11 - 13 October 2017

Tamoxifen loaded liposomes/nanoparticles

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., ALTINTAŞ L.

International Gazi Pharma Symposium Series, Antalya, Turkey, 12 - 15 November 2015

Development of raloxifene nanoparticles with absorption enhancers and investigation of transport properties through Caco-2 cell line

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., ALTINTAŞ L.

İnternational Multidisiplinary Symposium on Drug Research Development, Antalya, Turkey, 28 - 29 November 2013

Comparision of antitumoural and MMP-2 inhibition activity of dimethyl-β-cyclodextrin containing nanoparticles of raloxifene-tamoxifen

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş.

European Conference on Cyclodextrins, Antalya, Turkey, 2 - 04 October 2013

Development of tamoxifen loaded nanoparticles with absorption enhancers and investigation of transport properties through Caco-2 cell lines

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., ALTINTAŞ L.

16th International Pharmaceutical Technology Symposium, Antalya, Turkey, 10 September 2012, pp.156-158

Development of liposome formulation of rivastigmine with enhancers and investigation of transport properties through MDCK cell line

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., EŞSİZ D.

18 th International Symposium on Microencapsulation, Antalya, Turkey, 12 - 14 September 2011

Development of liposome formulations of rivastigmine with absorption enhancers and investigation of transport properties of liposomes through Caco-2

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., EŞSİZ D.

PBP World Meeting, Valletta, Malta, 8 - 11 March 2010

Development of liposome formulation of rivastigmine and investigation of transport properties through MDCK and Caco-2 cell lines

DEĞİM Z., MUTLU AĞARDAN N. B., YILMAZ Ş., EŞSİZ D.

3rd BBBB-Bosphorus Iternational Conference on Pharmaceutical Sciences, Antalya, Turkey, 26 - 28 October 2009

Investigation of rivastigmine transport through MDCK cell line

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., EŞSİZ D.

14th İnternational Pharmaceutical Technology Symposium, Antalya, Turkey, 8 - 11 September 2008

İnvestigation of rivastigmine transport through human colon carsinoma cells, Caco-2

MUTLU AĞARDAN N. B., DEĞİM Z., YILMAZ Ş., EŞSİZ D., ALTINTAŞ L., GÜNKAYA G.

35th Annual Meeting of Controlled Release Society, New York, United States Of America, 12 - 16 July 2008

Metrics

Publication

Citation (WoS)

250

H-Index (WoS)

Citation (Scopus)

285

H-Index (Scopus)

Citation (Scholar)

303

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

Books & Book Chapters

Metrics

Publication

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Thesis Advisory

Open Access